{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:41:53Z","timestamp":1795095713872,"version":"4.10.2"},"reference-count":123,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fibroblasts constitute a major component of our stroma, the supportive bedding in which our tissues reside. The introduction of advanced single-cell technologies has greatly enhanced our appreciation of fibroblast heterogeneity in health and immune-mediated inflammatory diseases (IMIDs). This heterogeneity correlates with their diverse functions, including providing architectural support, tissue identity, \u2018stromal memory\u2019, and regulating immune responses and fibrosis. In RA, fibroblasts contribute to both synovial inflammation and bone and cartilage damage, and in IBD to loss of the epithelial barrier, intestinal inflammation, and the development of intestinal strictures and fistulae in Crohn\u2019s disease. Fibroblasts have also been associated with non-response to current biologic therapies in RA and IBD. Targeting pathogenic fibroblast populations using new therapeutic modalities such as Chimeric Antigen Receptor (CAR) T-cell therapies may \u2018reset\u2019 the stroma back to health and give hope for cure in these debilitating IMIDs.<\/jats:p>","DOI":"10.1093\/rheumatology\/keag249","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:43:41Z","timestamp":1778327021000},"source":"Crossref","is-referenced-by-count":5,"title":["Targeting fibroblasts in immune mediated inflammatory diseases: a cellular basis for cure?"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7606-596X","authenticated-orcid":false,"given":"Mikalena","family":"Xenophontos","sequence":"first","affiliation":[{"name":"Kennedy Institute of Rheumatology, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0784-1323","authenticated-orcid":false,"given":"Fr\u00e4nze","family":"Progatzky","sequence":"additional","affiliation":[{"name":"Kennedy Institute of Rheumatology, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6924-6402","authenticated-orcid":false,"given":"Christopher D","family":"Buckley","sequence":"additional","affiliation":[{"name":"Kennedy Institute of Rheumatology, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"2026060613213967300_keag249-B1","first-page":"184","article-title":"[One hundred books which build up neurology\u2014Rudolf Ludwig Carl Virchow \"Die Cellularpathologie in ihrer Begrundung auf physiologische und pathologische Gewebelehre\"]","volume":"63","author":"Sakuta","year":"2011","journal-title":"Brain Nerve"},{"key":"2026060613213967300_keag249-B2","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1073\/pnas.162488599","article-title":"Diversity, topographic differentiation, and positional memory in human fibroblasts","volume":"99","author":"Chang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026060613213967300_keag249-B3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol Med"},{"key":"2026060613213967300_keag249-B4","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","article-title":"Epithelial-mesenchymal transition and its implications for fibrosis","volume":"112","author":"Kalluri","year":"2003","journal-title":"J Clin Invest"},{"key":"2026060613213967300_keag249-B5","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.4049\/jimmunol.166.12.7556","article-title":"Peripheral blood fibrocytes: differentiation pathway and migration to wound sites","volume":"166","author":"Abe","year":"2001","journal-title":"J Immunol"},{"key":"2026060613213967300_keag249-B6","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1038\/s41467-022-30633-9","article-title":"Identification, discrimination and heterogeneity of fibroblasts","volume":"13","author":"Lendahl","year":"2022","journal-title":"Nat Commun"},{"key":"2026060613213967300_keag249-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026060613213967300_keag249-B8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF02147594","article-title":"Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction","volume":"27","author":"Gabbiani","year":"1971","journal-title":"Experientia"},{"key":"2026060613213967300_keag249-B9","first-page":"171","article-title":"The role of myofibroblasts in wound healing","volume":"64","author":"Hinz","year":"2016","journal-title":"Curr Res Transl Med"},{"key":"2026060613213967300_keag249-B10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jbiomech.2009.09.020","article-title":"The myofibroblast: paradigm for a mechanically active cell","volume":"43","author":"Hinz","year":"2010","journal-title":"J Biomech"},{"key":"2026060613213967300_keag249-B11","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"key":"2026060613213967300_keag249-B12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2019.12.010","article-title":"TGF-\u03b21-A truly transforming growth factor in fibrosis and immunity","volume":"101","author":"Lodyga","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"2026060613213967300_keag249-B13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"2026060613213967300_keag249-B14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.24331","article-title":"Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis","volume":"60","author":"Miller","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2026060613213967300_keag249-B15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0945-053X(99)00030-X","article-title":"Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate","volume":"18","author":"Konttinen","year":"1999","journal-title":"Matrix Biol"},{"key":"2026060613213967300_keag249-B16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","article-title":"RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation","volume":"75","author":"Danks","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2026060613213967300_keag249-B17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.immuni.2017.01.004","article-title":"Autocrine loop involving IL-6 family member LIF, LIF receptor, and STAT4 drives sustained fibroblast production of inflammatory mediators","volume":"46","author":"Nguyen","year":"2017","journal-title":"Immunity"},{"key":"2026060613213967300_keag249-B18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"},{"key":"2026060613213967300_keag249-B19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.22573","article-title":"Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes","volume":"56","author":"Tran","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2026060613213967300_keag249-B20","first-page":"268","article-title":"Antigen-presenting capacity of rheumatoid synovial fibroblasts","volume":"82","author":"Boots","year":"1994","journal-title":"Immunology"},{"key":"2026060613213967300_keag249-B21","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1002\/art.24140","article-title":"Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis","volume":"58","author":"Ospelt","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026060613213967300_keag249-B22","first-page":"1007","article-title":"[Feather- and hair-forming properties of dermal cells of glabrous skin from bird and mammals]","volume":"281","author":"Dhouailly","year":"1975","journal-title":"C R Acad Hebd Seances Acad Sci D"},{"key":"2026060613213967300_keag249-B23","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1371\/journal.pgen.0020119","article-title":"Anatomic demarcation by positional variation in fibroblast gene expression programs","volume":"2","author":"Rinn","year":"2006","journal-title":"PLoS Genet"},{"key":"2026060613213967300_keag249-B24","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1038\/ncomms14852","article-title":"Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions","volume":"8","author":"Frank-Bertoncelj","year":"2017","journal-title":"Nat Commun"},{"key":"2026060613213967300_keag249-B25","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","article-title":"The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts","volume":"54","author":"Fri\u0161\u010di\u0107","year":"2021","journal-title":"Immunity"},{"key":"2026060613213967300_keag249-B26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2026060613213967300_keag249-B27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/nature05836","article-title":"Gene-specific control of inflammation by TLR-induced chromatin modifications","volume":"447","author":"Foster","year":"2007","journal-title":"Nature"},{"key":"2026060613213967300_keag249-B28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cei.13149","article-title":"Stroma: the forgotten cells of innate immune memory","volume":"193","author":"Crowley","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"2026060613213967300_keag249-B29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1172\/JCI93555","article-title":"Fibroblast heterogeneity: implications for human disease","volume":"128","author":"Lynch","year":"2018","journal-title":"J Clin Invest"},{"key":"2026060613213967300_keag249-B30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-021-03549-5","article-title":"Cross-tissue organization of the fibroblast lineage","volume":"593","author":"Buechler","year":"2021","journal-title":"Nature"},{"key":"2026060613213967300_keag249-B31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.medj.2022.05.002","article-title":"Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases","volume":"3","author":"Korsunsky","year":"2022","journal-title":"Med"},{"key":"2026060613213967300_keag249-B32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2026060613213967300_keag249-B33","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp Mol Med"},{"key":"2026060613213967300_keag249-B34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026060613213967300_keag249-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2022-002842","article-title":"Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease","volume":"9","author":"Leon","year":"2023","journal-title":"RMD Open"},{"key":"2026060613213967300_keag249-B36","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00296-023-05349-8","article-title":"Difficult to treat rheumatoid arthritis in a comprehensive evaluation program: frequency according to different objective evaluations","volume":"43","author":"Garcia-Salinas","year":"2023","journal-title":"Rheumatol Int"},{"key":"2026060613213967300_keag249-B37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41584-018-0134-1","article-title":"Author Correction: pathogenic stromal cells as therapeutic targets in joint inflammation","volume":"15","author":"Dakin","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2026060613213967300_keag249-B38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026060613213967300_keag249-B39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41584-022-00790-8","article-title":"Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission","volume":"18","author":"Kurowska-Stolarska","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2026060613213967300_keag249-B40","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.immuni.2024.11.004","article-title":"Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis","volume":"57","author":"MacDonald","year":"2024","journal-title":"Immunity"},{"key":"2026060613213967300_keag249-B41","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1038\/s41467-024-52586-x","article-title":"Adipocyte associated glucocorticoid signaling regulates normal fibroblast function which is lost in inflammatory arthritis","volume":"15","author":"Faust","year":"2024","journal-title":"Nat Commun"},{"key":"2026060613213967300_keag249-B42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0306-4522(90)90199-E","article-title":"Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis","volume":"37","author":"Mapp","year":"1990","journal-title":"Neuroscience"},{"key":"2026060613213967300_keag249-B43","first-page":"1592","article-title":"Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis","volume":"17","author":"Pereira da Silva","year":"1990","journal-title":"J Rheumatol"},{"key":"2026060613213967300_keag249-B44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41467-018-02892-y","article-title":"Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis","volume":"9","author":"Mizoguchi","year":"2018","journal-title":"Nat Commun"},{"key":"2026060613213967300_keag249-B45","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1136\/annrheumdis-2019-215903","article-title":"Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients\u2019 by Buch et al","volume":"79","author":"Humby","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2026060613213967300_keag249-B46","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","article-title":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","volume":"623","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"2026060613213967300_keag249-B47","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41591-022-01789-0","article-title":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","volume":"28","author":"Rivellese","year":"2022","journal-title":"Nat Med"},{"key":"2026060613213967300_keag249-B48","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep"},{"key":"2026060613213967300_keag249-B49","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3389\/fimmu.2020.00845","article-title":"A Pauci-immune synovial pathotype predicts inadequate response to TNFalpha-blockade in rheumatoid arthritis patients","volume":"11","author":"Nerviani","year":"2020","journal-title":"Front Immunol"},{"key":"2026060613213967300_keag249-B50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","article-title":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","volume":"397","author":"Humby","year":"2021","journal-title":"Lancet"},{"key":"2026060613213967300_keag249-B51","doi-asserted-by":"crossref","first-page":"eadf2675","DOI":"10.1126\/sciadv.adf2675","article-title":"A Thy-1-negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials","volume":"10","author":"Abebayehu","year":"2024","journal-title":"Sci Adv"},{"key":"2026060613213967300_keag249-B52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0002-9440(10)62982-3","article-title":"Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis","volume":"167","author":"Hagood","year":"2005","journal-title":"Am J Pathol"},{"key":"2026060613213967300_keag249-B53","doi-asserted-by":"crossref","first-page":"119824","DOI":"10.1016\/j.biomaterials.2020.119824","article-title":"Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure","volume":"236","author":"Li","year":"2020","journal-title":"Biomaterials"},{"key":"2026060613213967300_keag249-B54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biocel.2018.01.009","article-title":"CD90(+) cardiac fibroblasts reduce fibrosis of acute myocardial injury in rats","volume":"96","author":"Chang","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"2026060613213967300_keag249-B55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","article-title":"Notch signalling drives synovial fibroblast identity and arthritis pathology","volume":"582","author":"Wei","year":"2020","journal-title":"Nature"},{"key":"2026060613213967300_keag249-B56","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41590-024-01774-4","article-title":"CD200(+) fibroblasts form a pro-resolving mesenchymal network in arthritis","volume":"25","author":"Rauber","year":"2024","journal-title":"Nat Immunol"},{"key":"2026060613213967300_keag249-B57","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/s44320-025-00149-7","article-title":"Synovial matrix turnover controls immune cell spatial patterning in inflammation resolution","volume":"21","author":"Richard","year":"2025","journal-title":"Mol Syst Biol"},{"key":"2026060613213967300_keag249-B58","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41590-025-02386-2","article-title":"Spatial patterning of fibroblast TGFbeta signaling underlies treatment resistance in rheumatoid arthritis","volume":"27","author":"Bhamidipati","year":"2026","journal-title":"Nat Immunol"},{"key":"2026060613213967300_keag249-B59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00296-004-0449-x","article-title":"The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis","volume":"25","author":"Ueno","year":"2005","journal-title":"Rheumatol Int"},{"key":"2026060613213967300_keag249-B60","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1136\/ard.2011.150219","article-title":"A BAFF\/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells","volume":"70","author":"Bombardieri","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2026060613213967300_keag249-B61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.aag3358","article-title":"Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis","volume":"2","author":"Carmona-Rivera","year":"2017","journal-title":"Sci Immunol"},{"key":"2026060613213967300_keag249-B62","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis","volume":"7","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2026060613213967300_keag249-B63","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/ard.2008.106021","article-title":"Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis","volume":"69","author":"J\u00fcngel","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026060613213967300_keag249-B64","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.39414","article-title":"Selective inhibition of membrane type 1 matrix metalloproteinase abrogates progression of experimental inflammatory arthritis: synergy with tumor necrosis factor blockade","volume":"68","author":"Kaneko","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026060613213967300_keag249-B65","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41590-022-01285-0","article-title":"ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts","volume":"23","author":"Yan","year":"2022","journal-title":"Nat Immunol"},{"key":"2026060613213967300_keag249-B66","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20041545","article-title":"Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes","volume":"200","author":"Valencia","year":"2004","journal-title":"J Exp Med"},{"key":"2026060613213967300_keag249-B67","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1073\/pnas.1019437108","article-title":"Cadherin-11 regulates fibroblast inflammation","volume":"108","author":"Chang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026060613213967300_keag249-B68","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1137306","article-title":"Cadherin-11 in synovial lining formation and pathology in arthritis","volume":"315","author":"Lee","year":"2007","journal-title":"Science"},{"key":"2026060613213967300_keag249-B69","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/art.40428","article-title":"Identification of three rheumatoid arthritis disease subtypes by machine learning integration of synovial histologic features and RNA sequencing data","volume":"70","author":"Orange","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2026060613213967300_keag249-B70","doi-asserted-by":"crossref","first-page":"812962","DOI":"10.3389\/fimmu.2022.812962","article-title":"The neuroimmune interplay in joint pain: the role of macrophages","volume":"13","author":"Vasconcelos","year":"2022","journal-title":"Front Immunol"},{"key":"2026060613213967300_keag249-B71","doi-asserted-by":"crossref","first-page":"eadk3506","DOI":"10.1126\/scitranslmed.adk3506","article-title":"Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis","volume":"16","author":"Bai","year":"2024","journal-title":"Sci Transl Med"},{"key":"2026060613213967300_keag249-B72","doi-asserted-by":"crossref","first-page":"w13529","DOI":"10.4414\/smw.2012.13529","article-title":"Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer","volume":"142","author":"Juarez","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"2026060613213967300_keag249-B73","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/annrheumdis-2018-214783","article-title":"TNF-induced inflammatory genes escape repression in fibroblast-like synoviocytes: transcriptomic and epigenomic analysis","volume":"78","author":"Loh","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026060613213967300_keag249-B74","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1038\/s41467-024-48620-7","article-title":"The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis","volume":"15","author":"Weinand","year":"2024","journal-title":"Nat Commun"},{"key":"2026060613213967300_keag249-B75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-022-04919-3","article-title":"Inflammatory memory and tissue adaptation in sickness and in health","volume":"607","author":"Naik","year":"2022","journal-title":"Nature"},{"key":"2026060613213967300_keag249-B76","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/art.42240","article-title":"Joint-specific memory and sustained risk for new joint accumulation in autoimmune arthritis","volume":"74","author":"Chang","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026060613213967300_keag249-B77","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/ecco-jcc\/jjae082","article-title":"Epidemiology of inflammatory bowel disease across the ages in the era of advanced therapies","volume":"18","author":"Caron","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026060613213967300_keag249-B78","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1038\/s41586-018-0286-9","article-title":"Author Correction: subepithelial telocytes are an important source of Wnts that supports intestinal crypts","volume":"560","author":"Shoshkes-Carmel","year":"2018","journal-title":"Nature"},{"key":"2026060613213967300_keag249-B79","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.stem.2020.01.008","article-title":"Distinct mesenchymal cell populations generate the essential intestinal BMP signaling gradient","volume":"26","author":"McCarthy","year":"2020","journal-title":"Cell Stem Cell"},{"key":"2026060613213967300_keag249-B80","doi-asserted-by":"crossref","first-page":"e3001032","DOI":"10.1371\/journal.pbio.3001032","article-title":"Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis","volume":"18","author":"Brugger","year":"2020","journal-title":"PLoS Biol"},{"key":"2026060613213967300_keag249-B81","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","article-title":"Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease","volume":"175","author":"Kinchen","year":"2018","journal-title":"Cell"},{"key":"2026060613213967300_keag249-B82","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.cell.2024.03.013","article-title":"Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling","volume":"187","author":"Cadinu","year":"2024","journal-title":"Cell"},{"key":"2026060613213967300_keag249-B83","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.immuni.2023.10.017","article-title":"The landscape of immune dysregulation in Crohn\u2019s disease revealed through single-cell transcriptomic profiling in the ileum and colon","volume":"56","author":"Kong","year":"2023","journal-title":"Immunity"},{"key":"2026060613213967300_keag249-B84","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41588-025-02225-y","article-title":"Single-cell and spatial transcriptomics of stricturing Crohn\u2019s disease highlights a fibrosis-associated network","volume":"57","author":"Kong","year":"2025","journal-title":"Nat Genet"},{"key":"2026060613213967300_keag249-B85","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/ecco-jcc\/jjab005","article-title":"Degree of creeping fat assessed by computed tomography enterography is associated with intestinal fibrotic stricture in patients with Crohn\u2019s disease: a potentially novel mesenteric creeping fat index","volume":"15","author":"Li","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2026060613213967300_keag249-B86","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1016\/j.cell.2025.08.029","article-title":"Creeping fat-derived mechanosensitive fibroblasts drive intestinal fibrosis in Crohn\u2019s disease strictures","volume":"188","author":"Bauer-Rowe","year":"2025","journal-title":"Cell"},{"key":"2026060613213967300_keag249-B87","first-page":"703","author":"McGregor","year":"2025"},{"key":"2026060613213967300_keag249-B88","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm.4307","article-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"West","year":"2017","journal-title":"Nat Med"},{"key":"2026060613213967300_keag249-B89","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41591-021-01520-5","article-title":"IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies","volume":"27","author":"Friedrich","year":"2021","journal-title":"Nat Med"},{"key":"2026060613213967300_keag249-B90","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/s41590-024-01994-8","article-title":"A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease","volume":"25","author":"Thomas","year":"2024","journal-title":"Nat Immunol"},{"key":"2026060613213967300_keag249-B91","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ecco-jcc\/jjz147","article-title":"Cadherin-11 is a regulator of intestinal fibrosis","volume":"14","author":"Franz\u00e8","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026060613213967300_keag249-B92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/annrheumdis-2019-eular.3028","article-title":"OP0224 results of a phase 2 study of RG6125, an anti-cadherin-11 monoclonal antibody, in rheumatoid arthritis patients with an inadequate response to anti-TNFalpha therapy","volume":"78","author":"Finch","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026060613213967300_keag249-B93","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026060613213967300_keag249-B94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrrheum.2015.157","article-title":"Successes and failures of chemokine-pathway targeting in rheumatoid arthritis","volume":"12","author":"Szekanecz","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2026060613213967300_keag249-B95","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/art.21975","article-title":"A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis","volume":"54","author":"Haringman","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2026060613213967300_keag249-B96","doi-asserted-by":"crossref","first-page":"iii62","DOI":"10.1136\/ard.60.90003.iii62","article-title":"Matrix metalloproteinase inhibitors in rheumatic diseases","volume":"60(Suppl 3)","author":"Close","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"2026060613213967300_keag249-B97","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1568010054022141","article-title":"Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases","volume":"4","author":"Milner","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"2026060613213967300_keag249-B98","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMc2107725","article-title":"CD19-targeted CAR T cells in refractory systemic lupus erythematosus","volume":"385","author":"Mougiakakos","year":"2021","journal-title":"N Engl J Med"},{"key":"2026060613213967300_keag249-B99","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(23)00521-4","article-title":"T-cell-engaging bispecific antibodies in cancer","volume":"402","author":"van de Donk","year":"2023","journal-title":"Lancet"},{"key":"2026060613213967300_keag249-B100","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJMc2508023","article-title":"CD19 CAR T-cell therapy in multidrug-resistant ulcerative colitis","volume":"393","author":"M\u00fcller","year":"2025","journal-title":"N Engl J Med"},{"key":"2026060613213967300_keag249-B101","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","article-title":"CAR T-cell therapy in autoimmune diseases","volume":"402","author":"Schett","year":"2023","journal-title":"Lancet"},{"key":"2026060613213967300_keag249-B102","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/S2665-9913(24)00377-1","article-title":"CAR T-cell therapy in autoimmune diseases: where are we and where are we going?","volume":"7","author":"Scherlinger","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"2026060613213967300_keag249-B103","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41577-024-01035-3","article-title":"Chimeric antigen receptor T cell therapy for autoimmune disease","volume":"24","author":"Chung","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"2026060613213967300_keag249-B104","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMc2509522","article-title":"In vivo CD19 CAR T-cell therapy for refractory systemic lupus erythematosus","volume":"393","author":"Wang","year":"2025","journal-title":"N Engl J Med"},{"key":"2026060613213967300_keag249-B105","doi-asserted-by":"crossref","first-page":"934343","DOI":"10.3389\/fimmu.2022.934343","article-title":"Regulatory CAR-T cells in autoimmune diseases: progress and current challenges","volume":"13","author":"Riet","year":"2022","journal-title":"Front Immunol"},{"key":"2026060613213967300_keag249-B106","doi-asserted-by":"crossref","first-page":"732135","DOI":"10.3389\/fimmu.2021.732135","article-title":"Current perspectives on \"Off-The-Shelf\" allogeneic NK and CAR-NK cell therapies","volume":"12","author":"Heipertz","year":"2021","journal-title":"Front Immunol"},{"key":"2026060613213967300_keag249-B107","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41591-024-02964-1","article-title":"Bispecific T cell engager therapy for refractory rheumatoid arthritis","volume":"30","author":"Bucci","year":"2024","journal-title":"Nat Med"},{"key":"2026060613213967300_keag249-B108","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJMc2408786","article-title":"BCMA-targeted T-cell-engager therapy for autoimmune disease","volume":"391","author":"Hagen","year":"2024","journal-title":"N Engl J Med"},{"key":"2026060613213967300_keag249-B109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20240499","article-title":"CD19-directed T cell-engaging antibodies for the treatment of autoimmune disease","volume":"221","author":"Michaelson","year":"2024","journal-title":"J Exp Med"},{"key":"2026060613213967300_keag249-B110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00262-003-0496-2","article-title":"T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent","volume":"53","author":"Gruen","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"2026060613213967300_keag249-B111","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia","volume":"376","author":"Kantarjian","year":"2017","journal-title":"N Engl J Med"},{"key":"2026060613213967300_keag249-B112","article-title":"A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells","volume":"30(","author":"Curioni","year":"2019","journal-title":"Ann Oncol"},{"key":"2026060613213967300_keag249-B113","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"2026060613213967300_keag249-B114","doi-asserted-by":"crossref","first-page":"1617487","DOI":"10.3389\/or.2025.1617487","article-title":"Fibroblast activation protein and the tumour microenvironment: challenges and therapeutic opportunities","volume":"19","author":"Lee","year":"2025","journal-title":"Oncol Rev"},{"key":"2026060613213967300_keag249-B115","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1016\/S1470-2045(17)30379-0","article-title":"Targeted radionuclide therapy in combined-modality regimens","volume":"18","author":"Gill","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026060613213967300_keag249-B116","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/RLU.0000000000003667","article-title":"Safety of fibroblast activation protein-targeted radionuclide therapy by a low-dose dosimetric approach using 177Lu-FAPI04","volume":"46","author":"Kuyumcu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"2026060613213967300_keag249-B117","first-page":"44","article-title":"Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer","volume":"26","author":"Hofheinz","year":"2003","journal-title":"Onkologie"},{"key":"2026060613213967300_keag249-B118","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/cbt.6.11.4874","article-title":"Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer","volume":"6","author":"Narra","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"2026060613213967300_keag249-B119","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/j.1349-7006.2010.01695.x","article-title":"Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model","volume":"101","author":"Wen","year":"2010","journal-title":"Cancer Sci"},{"key":"2026060613213967300_keag249-B120","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/rheumatology\/kem222","article-title":"Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation","volume":"46","author":"Vergunst","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2026060613213967300_keag249-B121","first-page":"S274","article-title":"Safety and efficacy of the humanized anti-C5 antibody h5G1.1 in patients with rheumatoid arthritis","volume":"44","author":"Tesser","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2026060613213967300_keag249-B122","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/annrheumdis-2014-205809","article-title":"The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts","volume":"75","author":"Klein","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2026060613213967300_keag249-B123","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/art.39608","article-title":"Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes","volume":"68","author":"Garcia-Carbonell","year":"2016","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag249\/68273292\/keag249.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/6\/keag249\/68273292\/keag249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/6\/keag249\/68273292\/keag249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T17:22:03Z","timestamp":1780766523000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag249\/8676500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag249","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,5,11]]},"article-number":"keag249"}}